James Martin shared on LinkedIn:
“Happy to share our real-world data at ASH24 that thrombosis risk may be higher than previously thought among our patients with breast cancer on targeted therapies.”
James Martin shared on LinkedIn:
“Happy to share our real-world data at ASH24 that thrombosis risk may be higher than previously thought among our patients with breast cancer on targeted therapies.”